KENVUE INC (KVUE) Stock Price & Overview
NYSE:KVUE • US49177J1025
The current stock price of KVUE is 17.65 USD. Today KVUE is down by -1.73%. In the past month the price decreased by -3.66%. In the past year, price decreased by -22.62%.
KVUE Key Statistics
- Market Cap
- 33.83B
- P/E
- 16.34
- Fwd P/E
- 15.29
- EPS (TTM)
- 1.08
- Dividend Yield
- 4.55%
KVUE Stock Performance
KVUE Stock Chart
KVUE Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to KVUE. When comparing the yearly performance of all stocks, KVUE is a bad performer in the overall market: 77.86% of all stocks are doing better.
KVUE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to KVUE. KVUE has a medium profitability rating, but doesn't score so well on its financial health evaluation.
KVUE Earnings
On February 17, 2026 KVUE reported an EPS of 0.27 and a revenue of 3.78B. The company beat EPS expectations (19.68% surprise) and beat revenue expectations (0.69% surprise).
KVUE Forecast & Estimates
20 analysts have analysed KVUE and the average price target is 20.33 USD. This implies a price increase of 15.18% is expected in the next year compared to the current price of 17.65.
For the next year, analysts expect an EPS growth of 6.87% and a revenue growth 3.45% for KVUE
KVUE Groups
Sector & Classification
KVUE Financial Highlights
Over the last trailing twelve months KVUE reported a non-GAAP Earnings per Share(EPS) of 1.08. The EPS decreased by -5.26% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.72% | ||
| ROA | 5.43% | ||
| ROE | 13.66% | ||
| Debt/Equity | 0.72 |
KVUE Ownership
KVUE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EL | ESTEE LAUDER COMPANIES-CL A | 29.71 | 34.1B | ||
| ELF | ELF BEAUTY INC | 21.57 | 4.753B | ||
| IPAR | INTERPARFUMS INC | 18.62 | 3.015B | ||
| COTY | COTY INC-CL A | 6.13 | 2.05B | ||
| BRBR | BELLRING BRANDS INC | 7.92 | 2.004B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 9.24 | 963.366M | ||
| OLPX | OLAPLEX HOLDINGS INC | 13.43 | 867.763M | ||
| NATR | NATURES SUNSHINE PRODS INC | 24.27 | 438.9M | ||
| NAGE | NIAGEN BIOSCIENCE INC | 16.25 | 416.608M | ||
| NUS | NU SKIN ENTERPRISES INC - A | 7.24 | 354.718M | ||
| HNST | HONEST CO INC/THE | 35.3 | 326.163M | ||
| USNA | USANA HEALTH SCIENCES INC | 8.63 | 325.932M |
Related stock screener links
View all stocks in the Personal Care Products Industry | View all stocks in the Consumer Staples Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About KVUE
Company Profile
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. The company is headquartered in Summit, New Jersey and currently employs 21,780 full-time employees. The company went IPO on 2023-05-04. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Company Info
IPO: 2023-05-04
KENVUE INC
1 Kenvue Way
Summit NEW JERSEY US
Employees: 21780
Phone: 19088741200
KENVUE INC / KVUE FAQ
What does KVUE do?
Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. The company is headquartered in Summit, New Jersey and currently employs 21,780 full-time employees. The company went IPO on 2023-05-04. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
What is the current price of KVUE stock?
The current stock price of KVUE is 17.65 USD. The price decreased by -1.73% in the last trading session.
Does KVUE stock pay dividends?
KENVUE INC (KVUE) has a dividend yield of 4.55%. The yearly dividend amount is currently 0.83.
What is the ChartMill rating of KENVUE INC stock?
KVUE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
Would investing in KENVUE INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on KVUE.
What is KENVUE INC worth?
KENVUE INC (KVUE) has a market capitalization of 33.83B USD. This makes KVUE a Large Cap stock.
Can you provide the short interest for KVUE stock?
The outstanding short interest for KENVUE INC (KVUE) is 3.09% of its float.